Trevi Therapeutics, Inc. financial data

Symbol
TRVI on Nasdaq
Location
195 Church Street, 14 Th Floor, New Haven, CT
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.74K % +54.5%
Debt-to-equity 6.51 % -40.6%
Return On Equity -31.2 % +50.7%
Return On Assets -29.3 % +48.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares +66.8%
Common Stock, Shares, Outstanding 128M shares +69.9%
Entity Public Float 180M USD +70.2%
Common Stock, Value, Issued 128K USD +70.7%
Weighted Average Number of Shares Outstanding, Basic 145M shares +43.3%
Weighted Average Number of Shares Outstanding, Diluted 145M shares +43.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 36.6M USD +0.13%
General and Administrative Expense 14.7M USD +26.5%
Operating Income (Loss) -51.4M USD -6.5%
Nonoperating Income (Expense) 5.46M USD +41.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -45.9M USD -3.48%
Income Tax Expense (Benefit) -30K USD -3.45%
Net Income (Loss) Attributable to Parent -45.9M USD -3.48%
Earnings Per Share, Basic 0 USD/shares +15.9%
Earnings Per Share, Diluted 0 USD/shares +15.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 56.9M USD +254%
Marketable Securities, Current 138M USD +179%
Other Assets, Current 2M USD +199%
Assets, Current 198M USD +194%
Property, Plant and Equipment, Net 213K USD +22.4%
Operating Lease, Right-of-Use Asset 741K USD -23.8%
Other Assets, Noncurrent 103K USD -59.8%
Assets 199M USD +189%
Accounts Payable, Current 2.71M USD +67.8%
Accrued Liabilities, Current 6.04M USD -16.3%
Liabilities, Current 9.04M USD -0.9%
Operating Lease, Liability, Noncurrent 527K USD -35.4%
Liabilities 9.57M USD -3.73%
Accumulated Other Comprehensive Income (Loss), Net of Tax 30K USD -78.4%
Retained Earnings (Accumulated Deficit) -321M USD -16.6%
Stockholders' Equity Attributable to Parent 190M USD +222%
Liabilities and Equity 199M USD +189%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.5M USD -28.8%
Net Cash Provided by (Used in) Financing Activities 8.71M USD
Net Cash Provided by (Used in) Investing Activities -9.95M USD -23%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 128M shares +69.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.7M USD +20.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 56.9M USD +254%
Deferred Tax Assets, Valuation Allowance 82.4M USD +18.6%
Deferred Tax Assets, Gross 82.8M USD +18.2%
Operating Lease, Liability 823K USD -21.7%
Payments to Acquire Property, Plant, and Equipment 57K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46M USD -4.56%
Lessee, Operating Lease, Liability, to be Paid 937K USD -26%
Property, Plant and Equipment, Gross 385K USD +10%
Operating Lease, Liability, Current 296K USD +26%
Lessee, Operating Lease, Liability, to be Paid, Year Two 380K USD +3.26%
Lessee, Operating Lease, Liability, to be Paid, Year One 371K USD +6.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 114K USD -47.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 95K USD -74.8%
Deferred Tax Assets, Operating Loss Carryforwards 53.8M USD +6.94%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95K USD -74.8%
Operating Lease, Payments 347K USD +21.8%
Additional Paid in Capital 511M USD +52.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 37K USD +5.71%
Interest Expense 9K USD -99.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%